U.S. Medical Grade Sodium Bicarbonate Market
U.S. Medical Grade Sodium Bicarbonate Market - Overall Industry Analysis 2025
The U.S. medical grade sodium bicarbonate market for hospitals was valued at $61.50 million in 2014, and is projected to reach $67.10 million by 2016, growing at a CAGR of 4.4% from 2014 to 2016.
Sodium bicarbonate is a member of a class of medicines known as antacids, which is administered intravenously to increase plasma bicarbonate concentration, buffer excess hydrogen ions, and increase blood pH. This chemical is widely applicable in the medical industry for treatment of several conditions such as metabolic acidosis, cardiac arrest, and renal indications. The administration of sodium bicarbonate in the body helps to increase the plasma HCO3 concentration and restore the plasma pH within the normal range. Thus, it is widely used to normalize pH by neutralizing excessive stomach acids in patients suffering from acidosis.
The U.S. medical grade sodium bicarbonate market for hospitals is segmented based on state into Arizona, Nevada, New Mexico, Utah, Colorado, Oregon, Washington, and Hawaii.
Market Dynamics:
Drivers:
The major players profiled in the report are Amphastar Pharmaceuticals, Inc., Hospira, Inc. (Pfizer), Cardinal Health, Athenex, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Inc., Rugby Laboratories, Richmond Pharmaceuticals, Inc., and Menper Distributors Inc.
KEY TAKEAWAYS
MARKET LANDSCAPE
By State
The U.S. medical grade sodium bicarbonate market for hospitals was valued at $61.50 million in 2014, and is projected to reach $67.10 million by 2016, growing at a CAGR of 4.4% from 2014 to 2016.
Sodium bicarbonate is a member of a class of medicines known as antacids, which is administered intravenously to increase plasma bicarbonate concentration, buffer excess hydrogen ions, and increase blood pH. This chemical is widely applicable in the medical industry for treatment of several conditions such as metabolic acidosis, cardiac arrest, and renal indications. The administration of sodium bicarbonate in the body helps to increase the plasma HCO3 concentration and restore the plasma pH within the normal range. Thus, it is widely used to normalize pH by neutralizing excessive stomach acids in patients suffering from acidosis.
The U.S. medical grade sodium bicarbonate market for hospitals is segmented based on state into Arizona, Nevada, New Mexico, Utah, Colorado, Oregon, Washington, and Hawaii.
Market Dynamics:
Drivers:
- High incidence of acidosis-related disorders
- Increase in demand for sodium bicarbonate during heart surgery
- Rise in number of patients undergoing chemotherapy
- High dose can cause headache, nausea, and irritability
The major players profiled in the report are Amphastar Pharmaceuticals, Inc., Hospira, Inc. (Pfizer), Cardinal Health, Athenex, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Inc., Rugby Laboratories, Richmond Pharmaceuticals, Inc., and Menper Distributors Inc.
KEY TAKEAWAYS
MARKET LANDSCAPE
By State
- Arizona
- Nevada
- New Mexico
- Utah
- Colorado
- Oregon
- Washington
- Hawaii
CHAPTER ONE. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools
CHAPTER TWO. EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER THREE. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET SCENARIO
3.2.1. Derivation from soda ash
3.2.2. Product description and medical application
3.2.3. Current scenario of the market
3.2.3.1. Product recalled by Hospira, Inc.
3.2.3.2. Shortage of drugs available in the market
3.2.4. Addressing the shortage of sodium bicarbonate
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in geriatric population
3.3.1.2. Rise in awareness towards the benefits offered by the drug
3.3.2. Restraints
3.3.2.1. Adverse effects of the drug
3.3.3. Opportunity
3.3.3.1. Surge in demand for the drug
CHAPTER FOUR. U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Market size and forecast
CHAPTER FIVE. ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. MARKET SHARE, 2016
5.3.1. Hospira, Inc. (Pfizer, Inc.)
5.3.2. Amphastar Pharmaceuticals, Inc.
5.3.3. Athenex, Inc.
5.3.4. Others
CHAPTER SIX. NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. MARKET SHARE, 2016
6.3.1. Hospira, Inc. (Pfizer, Inc.)
6.3.2. Amphastar Pharmaceuticals, Inc.
6.3.3. Athenex, Inc.
6.3.4. Others
CHAPTER SEVEN. NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. MARKET SHARE, 2016
7.3.1. Hospira, Inc. (Pfizer, Inc.)
7.3.2. Amphastar Pharmaceuticals, Inc.
7.3.3. Athenex, Inc.
7.3.4. Others
CHAPTER EIGHT. UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
8.1. OVERVIEW
8.2. MARKET SIZE AND FORECAST
8.3. MARKET SHARE, 2016
8.3.1. Hospira, Inc. (Pfizer, Inc.)
8.3.2. Amphastar Pharmaceuticals, Inc.
8.3.3. Athenex, Inc.
8.3.4. Others
CHAPTER NINE. COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
9.1. OVERVIEW
9.2. MARKET SIZE AND FORECAST
9.3. MARKET SHARE, 2016
9.3.1. Hospira, Inc. (Pfizer, Inc.)
9.3.2. Amphastar Pharmaceuticals, Inc.
9.3.3. Athenex, Inc.
9.3.4. Others
CHAPTER TEN. OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
10.1. OVERVIEW
10.2. MARKET SIZE AND FORECAST
10.3. MARKET SHARE, 2016
10.3.1. Hospira, Inc. (Pfizer, Inc.)
10.3.2. Amphastar Pharmaceuticals, Inc.
10.3.3. Athenex, Inc.
10.3.4. Others
CHAPTER ELEVEN. WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
11.1. OVERVIEW
11.2. MARKET SIZE AND FORECAST
11.3. MARKET SHARE, 2016
11.3.1. Hospira, Inc. (Pfizer, Inc.)
11.3.2. Amphastar Pharmaceuticals, Inc.
11.3.3. Athenex, Inc.
11.3.4. Others
CHAPTER TWELVE. HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
12.1. OVERVIEW
12.2. MARKET SIZE AND FORECAST
12.3. MARKET SHARE ANALYSIS, 2016
12.3.1. Hospira, Inc. (Pfizer, Inc.)
12.3.2. Amphastar Pharmaceuticals, Inc.
12.3.3. Athenex, Inc.
12.3.4. Others
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools
CHAPTER TWO. EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER THREE. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET SCENARIO
3.2.1. Derivation from soda ash
3.2.2. Product description and medical application
3.2.3. Current scenario of the market
3.2.3.1. Product recalled by Hospira, Inc.
3.2.3.2. Shortage of drugs available in the market
3.2.4. Addressing the shortage of sodium bicarbonate
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in geriatric population
3.3.1.2. Rise in awareness towards the benefits offered by the drug
3.3.2. Restraints
3.3.2.1. Adverse effects of the drug
3.3.3. Opportunity
3.3.3.1. Surge in demand for the drug
CHAPTER FOUR. U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Market size and forecast
CHAPTER FIVE. ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. MARKET SHARE, 2016
5.3.1. Hospira, Inc. (Pfizer, Inc.)
5.3.2. Amphastar Pharmaceuticals, Inc.
5.3.3. Athenex, Inc.
5.3.4. Others
CHAPTER SIX. NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
6.1. OVERVIEW
6.2. MARKET SIZE AND FORECAST
6.3. MARKET SHARE, 2016
6.3.1. Hospira, Inc. (Pfizer, Inc.)
6.3.2. Amphastar Pharmaceuticals, Inc.
6.3.3. Athenex, Inc.
6.3.4. Others
CHAPTER SEVEN. NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
7.1. OVERVIEW
7.2. MARKET SIZE AND FORECAST
7.3. MARKET SHARE, 2016
7.3.1. Hospira, Inc. (Pfizer, Inc.)
7.3.2. Amphastar Pharmaceuticals, Inc.
7.3.3. Athenex, Inc.
7.3.4. Others
CHAPTER EIGHT. UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
8.1. OVERVIEW
8.2. MARKET SIZE AND FORECAST
8.3. MARKET SHARE, 2016
8.3.1. Hospira, Inc. (Pfizer, Inc.)
8.3.2. Amphastar Pharmaceuticals, Inc.
8.3.3. Athenex, Inc.
8.3.4. Others
CHAPTER NINE. COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
9.1. OVERVIEW
9.2. MARKET SIZE AND FORECAST
9.3. MARKET SHARE, 2016
9.3.1. Hospira, Inc. (Pfizer, Inc.)
9.3.2. Amphastar Pharmaceuticals, Inc.
9.3.3. Athenex, Inc.
9.3.4. Others
CHAPTER TEN. OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
10.1. OVERVIEW
10.2. MARKET SIZE AND FORECAST
10.3. MARKET SHARE, 2016
10.3.1. Hospira, Inc. (Pfizer, Inc.)
10.3.2. Amphastar Pharmaceuticals, Inc.
10.3.3. Athenex, Inc.
10.3.4. Others
CHAPTER ELEVEN. WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
11.1. OVERVIEW
11.2. MARKET SIZE AND FORECAST
11.3. MARKET SHARE, 2016
11.3.1. Hospira, Inc. (Pfizer, Inc.)
11.3.2. Amphastar Pharmaceuticals, Inc.
11.3.3. Athenex, Inc.
11.3.4. Others
CHAPTER TWELVE. HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS
12.1. OVERVIEW
12.2. MARKET SIZE AND FORECAST
12.3. MARKET SHARE ANALYSIS, 2016
12.3.1. Hospira, Inc. (Pfizer, Inc.)
12.3.2. Amphastar Pharmaceuticals, Inc.
12.3.3. Athenex, Inc.
12.3.4. Others
LIST OF TABLES
TABLE CURRENT AND RESOLVED DRUG SHORTAGE AND DISCONTINUATIONS REPORTED TO FDA
TABLE U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE CURRENT AND RESOLVED DRUG SHORTAGE AND DISCONTINUATIONS REPORTED TO FDA
TABLE U.S. MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE ARIZONA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEVADA MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE NEW MEXICO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE UTAH MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE COLORADO MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE OREGON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE WASHINGTON MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, BY STATE, 2014-2016 ($MILLION)
TABLE HOSPITAL BEDS PER 1,000 POPULATION BY OWNERSHIP TYPE
TABLE HAWAII MEDICAL GRADE SODIUM BICARBONATE MARKET FOR HOSPITALS, 2014-2016 ($MILLION)
LIST OF FIGURES
FIGURE SODA ASH COMPONENTS AND USE
FIGURE SODA ASH CONSUMPTION BY SEGMENTS
FIGURE ARIZONA MARKET SHARE ANALYSIS, 2016
FIGURE NEVADA MARKET SHARE ANALYSIS, 2016
FIGURE NEW MEXICO MARKET SHARE ANALYSIS, 2016
FIGURE UTAH MARKET SHARE ANALYSIS, 2016
FIGURE COLORADO MARKET SHARE ANALYSIS, 2016
FIGURE OREGON MARKET SHARE ANALYSIS, 2016
FIGURE WASHINGTON MARKET SHARE ANALYSIS, 2016
FIGURE HAWAII MARKET SHARE ANALYSIS, 2016
FIGURE SODA ASH COMPONENTS AND USE
FIGURE SODA ASH CONSUMPTION BY SEGMENTS
FIGURE ARIZONA MARKET SHARE ANALYSIS, 2016
FIGURE NEVADA MARKET SHARE ANALYSIS, 2016
FIGURE NEW MEXICO MARKET SHARE ANALYSIS, 2016
FIGURE UTAH MARKET SHARE ANALYSIS, 2016
FIGURE COLORADO MARKET SHARE ANALYSIS, 2016
FIGURE OREGON MARKET SHARE ANALYSIS, 2016
FIGURE WASHINGTON MARKET SHARE ANALYSIS, 2016
FIGURE HAWAII MARKET SHARE ANALYSIS, 2016
